Novartis taps Molecular Partners for a novel approach to combat COVID-19 Novartis is spending USD 69 million upfront on a pair of experimental drugs from Molecular Partners. The pact is for MP0420 ...
Bayer Set to Fork Over USD 4 Billion for AskBio’s Gene Therapies Germany-based Bayer is set to acquire North Carolina-based Asklepios BioPharmaceutical (AskBio) with motives to get its hands on its gene therapies. Bayer will pay USD 2 billion in upfront payment in exchange for AskBio's AAV-based gene th...
Find MoreGSK eyes robust immune response from RSV vaccine Cold viruses mostly do not get much attention in terms of R&D. They usually make humans feel miserable for a few days, and later than clear up. However, some cold viruses can hit vulnerable people much harder, which leads to pneumonia and hospitalizations. Th...
Find MoreFull FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia The US FDA has granted its full approval to Venclexta (venetoclax) for newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older who are unfit for intensive induction chemotherapies. The approval is based on the res...
Find MoreThe immune cells of the brain could treat neurodegenerative diseases Human behavior relies on the stimulation and inhibition of neurons, and scientists have long considered that neurons are mainly responsible for maintaining this circuit of activity in balance. However, now, a research team led by the Icahn Scho...
Find MoreInovio’s shares plunge after FDA holds-off its COVID-19 vaccine Phase II/III trial Inovio’s COVID-19 vaccine, INO-4800, Phase II/III clinical trials’ have been put under partial hold after the USFDA raised questions. The firm mentioned the reason behind the halt of the trials is not due to adverse events i...
Find MoreLilly links COVID-19 antibody to a reduce hospitalization rate Eli Lilly has linked its anti-SARS-CoV-2 antibody to a lower rate of hospitalization in patients lately diagnosed with mild to moderate cases of COVID-19. Nevertheless, two of the three doses, including the highest studied in the phase 2 trial, flunk...
Find MoreAstraZeneca/ Oxford resumes the trial of their COVID-19 vaccine in the UK After receiving a go-ahead from the UK’s Medicines Health Regulatory Authority, AstraZeneca and the University of Oxford have resumed the trials of their experimental coronavirus candidate AZD1222 in the country. A rapid review by the tria...
Find MorePfizer, BioNTech report shows the immune response in animals to COVID-19 Pfizer and its partner BioNTech have five potential COVID-19 vaccines in clinical trials, each based on a different mRNA format. The companies are now exhibiting that the most advanced candidate, BNT162b2, performed well in trials in ...
Find MoreCycle Pharmaceuticals Hauls In USD 25 Million In A Debt Financing Agreement Cycle Pharmaceuticals, a biotech company focusing exclusively on rare diseases, announced a strategic financing agreement worth USD25 million credit facility with Deutsche Bank AG. Headquartered in the UK, Cycle Pharmaceut...
Find MoreAn inherited disorder, Von Hippel-Lindau (VHL) syndrome is characterized by the formation of tumors .....
Find MoreVitiligo is a chronic complex pigment disorder where pale white patches develop on the skin. Any loc.....
Find MoreAAV Vectors are the leading viral vectors for gene delivery to treat a variety of human diseases. Ad.....
Find MoreA genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy w.....
Find MoreWith worldwide dissemination and now over 9 million cases and nearly 500,000 deaths recorded, the ef.....
Find MoreIn the past few years, online buying has become the easiest way to purchase products and services. T.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.